Nepal vs Paraguay: Tuberculosis patients living with HIV receiving antiretroviral therapy
Nepal
144 patients
in 2021
Paraguay
199 patients
in 2021
Nepal rank
72nd
Paraguay rank
69th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Nepal
- Paraguay
How they compare
Paraguay currently reports 199 patients against 144 patients in Nepal, a difference of 55 patients.
That makes Paraguay's figure about 1.4 times Nepal's.
The two have swapped places 6 times across 12 shared years of data; in 2010 it was Paraguay ahead.
Nepal ranks 72nd and Paraguay ranks 69th of 183 countries.
Paraguay has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nepal | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 144.2 patients | 146.6 patients | 2.4 patients | Paraguay |
| 2020s | 128.5 patients | 188.5 patients | 60 patients | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Nepal or Paraguay?
- Paraguay, at 199 patients against 144 patients in Nepal as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Nepal and Paraguay?
- 55 patients, with Paraguay ahead.
- How many years of comparable data are there for Nepal and Paraguay?
- 12 years are reported by both, from 2010 to 2021.
- How do Nepal and Paraguay rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Nepal ranks 72nd and Paraguay ranks 69th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.